Annual Total Debt
$825.15 M
+$83.70 M+11.29%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual total debt is currently $825.15 million, with the most recent change of +$83.70 million (+11.29%) on 31 December 2023. During the last 3 years, it has risen by +$545.65 million (+195.22%). BCRX annual total debt is now at all-time high.BCRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$809.14 M
-$12.53 M-1.52%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly total debt is currently $809.14 million, with the most recent change of -$12.53 million (-1.52%) on 30 September 2024. Over the past year, it has dropped by -$36.29 million (-4.29%). BCRX quarterly total debt is now -4.29% below its all-time high of $845.43 million, reached on 30 September 2023.BCRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.3% | -4.3% |
3 y3 years | +195.2% | +380.1% |
5 y5 years | +1234.7% | +857.3% |
BCRX Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +195.2% | -4.3% | +429.4% |
5 y | 5 years | at high | +1234.7% | -4.3% | +901.7% |
alltime | all time | at high | -4.3% |
BioCryst Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $809.14 M(-1.5%) |
June 2024 | - | $821.67 M(-0.6%) |
Mar 2024 | - | $826.88 M(+0.2%) |
Dec 2023 | $825.15 M(+11.3%) | $825.15 M(-2.4%) |
Sept 2023 | - | $845.43 M(+2.2%) |
June 2023 | - | $827.63 M(+9.6%) |
Mar 2023 | - | $755.36 M(+1.9%) |
Dec 2022 | $741.45 M(+25.0%) | $741.45 M(+2.7%) |
Sept 2022 | - | $721.81 M(+372.2%) |
June 2022 | - | $152.85 M(-75.1%) |
Mar 2022 | - | $613.00 M(+3.3%) |
Dec 2021 | $593.24 M(+112.2%) | $593.24 M(+252.0%) |
Sept 2021 | - | $168.54 M(+4.1%) |
June 2021 | - | $161.88 M(+2.5%) |
Mar 2021 | - | $157.92 M(-43.5%) |
Dec 2020 | $279.50 M(+230.2%) | $279.50 M(+246.0%) |
Sept 2020 | - | $80.78 M(-5.5%) |
June 2020 | - | $85.48 M(+0.3%) |
Mar 2020 | - | $85.24 M(+0.7%) |
Dec 2019 | $84.65 M(+36.9%) | $84.65 M(+0.2%) |
Sept 2019 | - | $84.52 M(+1.9%) |
June 2019 | - | $82.93 M(+5.2%) |
Mar 2019 | - | $78.85 M(+27.5%) |
Dec 2018 | $61.82 M(+13.0%) | $61.82 M(+0.2%) |
Sept 2018 | - | $61.70 M(+19.4%) |
June 2018 | - | $51.69 M(-2.9%) |
Mar 2018 | - | $53.21 M(-2.8%) |
Dec 2017 | $54.72 M(+1.9%) | $54.72 M(+0.4%) |
Sept 2017 | - | $54.52 M(+0.7%) |
June 2017 | - | $54.16 M(+0.4%) |
Mar 2017 | - | $53.94 M(+0.4%) |
Dec 2016 | $53.72 M(+78.0%) | $53.72 M(+0.5%) |
Sept 2016 | - | $53.47 M(+74.7%) |
June 2016 | - | $30.61 M(+0.6%) |
Mar 2016 | - | $30.42 M(+0.8%) |
Dec 2015 | $30.18 M(+0.6%) | $30.18 M(+0.6%) |
Sept 2015 | - | $30.00 M(0.0%) |
June 2015 | - | $30.00 M(0.0%) |
Mar 2015 | - | $30.00 M(0.0%) |
Dec 2014 | $30.00 M(0.0%) | $30.00 M(0.0%) |
Sept 2014 | - | $30.00 M(0.0%) |
June 2014 | - | $30.00 M(0.0%) |
Mar 2014 | - | $30.00 M(0.0%) |
Dec 2013 | $30.00 M(0.0%) | $30.00 M(0.0%) |
Sept 2013 | - | $30.00 M(0.0%) |
June 2013 | - | $30.00 M(0.0%) |
Mar 2013 | - | $30.00 M(0.0%) |
Dec 2012 | $30.00 M(0.0%) | $30.00 M(0.0%) |
Sept 2012 | - | $30.00 M(0.0%) |
June 2012 | - | $30.00 M(0.0%) |
Mar 2012 | - | $30.00 M(0.0%) |
Dec 2011 | $30.00 M(>+9900.0%) | $30.00 M(0.0%) |
Sept 2011 | - | $30.00 M(0.0%) |
June 2011 | - | $30.00 M(0.0%) |
Mar 2011 | - | $30.00 M(>+9900.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2010 | - | $0.00(0.0%) |
June 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00 | $0.00(0.0%) |
Sept 2009 | - | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
June 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2008 | - | $0.00(0.0%) |
June 2008 | - | $0.00(0.0%) |
Mar 2008 | - | $0.00(0.0%) |
Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2007 | - | $0.00(0.0%) |
June 2007 | - | $0.00(0.0%) |
Mar 2007 | - | $0.00(0.0%) |
Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2006 | - | $0.00(0.0%) |
June 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(0.0%) |
Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2005 | - | $0.00(0.0%) |
June 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) |
Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2004 | - | $0.00(0.0%) |
June 2004 | - | $0.00(0.0%) |
Mar 2004 | - | $0.00(0.0%) |
Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2003 | - | $0.00(0.0%) |
June 2003 | - | $0.00(0.0%) |
Mar 2003 | - | $0.00(0.0%) |
Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2002 | - | $0.00(0.0%) |
June 2002 | - | $0.00(0.0%) |
Mar 2002 | - | $0.00(0.0%) |
Dec 2001 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2001 | - | $0.00(0.0%) |
June 2001 | - | $0.00(-100.0%) |
Mar 2001 | - | $3000.00(-69.4%) |
Dec 2000 | $9800.00(>+9900.0%) | $9800.00(-42.4%) |
Sept 2000 | - | $17.00 K(-26.1%) |
June 2000 | - | $23.00 K(-20.7%) |
Mar 2000 | - | $29.00 K(>+9900.0%) |
Dec 1999 | $0.00(0.0%) | $0.00(0.0%) |
Sept 1999 | - | $0.00(0.0%) |
June 1999 | - | $0.00(0.0%) |
Mar 1999 | - | $0.00(0.0%) |
Dec 1998 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 1998 | - | $0.00(0.0%) |
June 1998 | - | $0.00(0.0%) |
Mar 1998 | - | $0.00(-100.0%) |
Dec 1997 | $100.00 K(-66.7%) | $100.00 K(0.0%) |
Sept 1997 | - | $100.00 K(-50.0%) |
June 1997 | - | $200.00 K(0.0%) |
Mar 1997 | - | $200.00 K(-33.3%) |
Dec 1996 | $300.00 K(-50.0%) | $300.00 K(-25.0%) |
Sept 1996 | - | $400.00 K(0.0%) |
June 1996 | - | $400.00 K(-20.0%) |
Mar 1996 | - | $500.00 K(-16.7%) |
Dec 1995 | $600.00 K(-33.3%) | $600.00 K(-14.3%) |
Sept 1995 | - | $700.00 K(+16.7%) |
June 1995 | - | $600.00 K(-14.3%) |
Mar 1995 | - | $700.00 K(-22.2%) |
Dec 1994 | $900.00 K | $900.00 K(0.0%) |
Sept 1994 | - | $900.00 K(-18.2%) |
June 1994 | - | $1.10 M(-8.3%) |
Mar 1994 | - | $1.20 M |
FAQ
- What is BioCryst Pharmaceuticals annual total debt?
- What is the all time high annual total debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual total debt year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly total debt year-on-year change?
What is BioCryst Pharmaceuticals annual total debt?
The current annual total debt of BCRX is $825.15 M
What is the all time high annual total debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total debt is $825.15 M
What is BioCryst Pharmaceuticals annual total debt year-on-year change?
Over the past year, BCRX annual total debt has changed by +$83.70 M (+11.29%)
What is BioCryst Pharmaceuticals quarterly total debt?
The current quarterly total debt of BCRX is $809.14 M
What is the all time high quarterly total debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total debt is $845.43 M
What is BioCryst Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, BCRX quarterly total debt has changed by -$36.29 M (-4.29%)